A new trading day began on Tuesday, with Cogent Biosciences Inc (NASDAQ: COGT) stock price down -8.84% from the previous day of trading, before settling in for the closing price of $15.5. COGT’s price has ranged from $3.72 to $17.15 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 10.02% over the last five years. Meanwhile, its annual earnings per share averaged 8.58%. With a float of $112.56 million, this company’s outstanding shares have now reached $139.70 million.
Cogent Biosciences Inc (COGT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 19.43%, while institutional ownership is 87.94%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.09 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.35% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Here are Cogent Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -1.84 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 2.89 million was better than the volume posted last year of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 42.53%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 70.58%, which indicates a significant increase from 4.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.92 in the past 14 days, which was higher than the 0.65 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.25, while its 200-day Moving Average is $9.39. Now, the first resistance to watch is $15.36. This is followed by the second major resistance level at $16.59. The third major resistance level sits at $17.28. If the price goes on to break the first support level at $13.44, it is likely to go to the next support level at $12.75. Should the price break the second support level, the third support level stands at $11.52.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
With a market capitalization of 1.97 billion, the company has a total of 113,856K Shares Outstanding. Currently, annual sales are 0 K while annual income is -255,860 K. The company’s previous quarter sales were 0 K while its latest quarter income was -73,530 K.
